Title | 5. diabetes drug table |
---|---|
Course | Pharmacology |
Institution | Texas Woman's University |
Pages | 4 |
File Size | 226.8 KB |
File Type | |
Total Downloads | 71 |
Total Views | 159 |
drug table from notes ...
Drug class and prototype
MOA/dynamics
Advantages
Disadvantages and side effects
Contraindications
Teaching Impleme Consider
Group 1 Biguanide
stops the liver from making glucose when its not needed
cost weight loss, insulin sensitization, positive lipid effect,
GI side effects (nausea, metallic taste, flatulence, diarrhea)
diabetes complicated by fever, severe infections, severe trauma, major surgery, acidosis, or pregnancy
given wit breakfas morning doses be
prototype: metformin
mild hypotensive effect.
rare lactic acidosis (liver disease)
conditions that may increase production of lactate
low risk of hypoglycemia
Group 2A: sulfonylureas prototypes: 1st generation: chlorpropamide
increase insulin output from the pancreas [make extra insulin]
oral; low cost, fast reduction in fasting glucose
weight gain, skin rash,
stop 2 da procedur decrease perfusion surgery eczema, erythem urticaria
severe renal or hepatic impairment
take with
type 1 diabetes or patients with DKA [diabetic ketoacidosis]
take 15-3 before ea
strong risk of hypoglycemia
carry sou carbohyd
work in pancreas
2nd generation: glyburide and glipizide
Group 2B: glinides prototype: repaglinide, nateglinide (Starlix)
stimulate pancreas to release more insulin
Very short acting (acts directly on beta cell)
lower risk for hypoglycemia, short acting, meal adjust dosing (flexible)
Cost: GI upset, upper respiratory congestion, hypoglycemia
short act side effe
Group 2C: incretin agents [two prototypes]
inhibits release of glucose from liver; stimulates insulin when glucose rises
gliptin [sitagliptin]
gliptin: inhibits glucose, PO
glutide: [liraglutide and glucagone-like peptide]
stimulates insulin, injection
Group 3: glitazones
inhibits release of glucose from liver)
prototypes: pioglitazone, rosiglitazone
helps body cells use insulin [address the core problem in type II diabetes—insulin resistance]
Group 4: starch blockers
lowered upper respiratory A1c, works well in infection, sore elderly, throat, diarrhea, headache, stuffy fewer side nose effects, take with other oral hypoglycemic agents
take without regard to means; decreases amount of insulin decrease risk of hypoglycemia, decrease in triglyceride level
slow digestion of decrease risk of starch hypoglycemia
prototypes: acarbose and miglitol
block renal glucose
given PO daily, weight loss, lower
production of ketones in the urine, end-stage renal disease, medication that cause hypoglycemia
monitor f effects risk of he DPP-4 in [gliptin] once dai without fo
cost; weight gain; don’t give with heart failure slow onset of [BBW] action (12 weeks); possible liver toxicity safety alert: risk of a heart attack liver injury and diarrhea, [MI] sinusitis, upper respiratory infection, rhinitis, and dyspnea.
monitor s transami
cost; potential to produce leukopenia, thrombocytopeni a, and anemia
contra: inflammatory bowel DKA, hepatic cirrhosis, and severe renal impairment
must be each me
don’t give with diuretics [can
monitor f itching (m
GI side effects (diarrhea, flatulence) SGLT2 Inhibitor (Gliflozin):
type 1 diabetes mellitus, insulin use,
same as contra and side effects
monitor b pressure presence before or minutes
Glucosuria prototype: canagliflozin, dapagliflozin
reabsorption
blood pressure
cause dehydration; possible reduced bone density; may cause ketoacidosis (high blood ketones)
promotes elimination of glucose
Type
name
Onset
Peak
Duration
Misc
Rapid-acting Insulin (analog)
lispro (Humalog) aspart (NovoLog) glulisine (Apidra)
about 15 (immediate)
30-1 hr
Effective SQ, IV, insulin Duration: 3-5 pump hours Ideal for bolus (mealtime and high glucose) 15 MINS FEELS LIKE AN HOUR DURING 3 RAPID RESPONSES
SHORT ACTING INSULIN
Intermediateacting Insulin
Regular: Humulin R , Novolin R, Actrapid
Humulin N, Novolin N (NPH)
Onset: 30-60 min
Onset: 2-4 hours
Peak 2-3 hours
Peak: 8-12 hours (hypoglycemia –
Duration: 5-7 hours
Effective duration 1824 hours
Clear/ give IV, SQ
SHORT STAFFED NURSES WENT FROM 30 PATIENTS TO (2) 8 patients Cloudy, Subq only **can be mixed with Regular
urinary tr infection
midafternoon)
Long-acting Insulin (analog)
glargine (Lantus) detemir (Levemir)
Onset: 3-4 hours
Peak: 8-16 hrs
18-20 hrs.
NURSES PLAY HEROES TO (2) EIGHT (8) 16 YEAR OLDS Adm Sq. (same time daily) Provides Basal THE THREE LONG NURSING SHIFTS NEVER PEAKED BUT LASTED 24 HOURS
Basal: glargine (long acting) any time, but usually at night (50% of total daily dose: TDD): keep basic metabolic functions even when not eating Nutritional (prandial or bolus) (50% of TDD): before meals Correctional (sliding scale): additional insulin depending on pt. condition to keep blood glucose within normal range...